MFG
BNGO icon

Magnus Financial Group’s Bionano Genomics BNGO Stock Holding History

Magnus Financial Group’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-21
Closed -$7.62K – 267
2023
Q2 		$7.62K Hold
21
– – ﹤0.01% 270
2023
Q1 		$13.9K Hold
21
– – ﹤0.01% 274
2022
Q4 		$18.2K Hold
21
– – ﹤0.01% 264
2022
Q3 		$23K Hold
21
– – ﹤0.01% 250
2022
Q2 		$18K Hold
21
– – ﹤0.01% 270
2022
Q1 		$33K Buy
+21
New +$28.3K 0.01% 287

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Magnus Financial Group's BNGO Position: Q3 2023 in Review

Magnus Financial Group sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 21 shares — an estimated $7.62K sold.

Magnus Financial Group first reported a position in BNGO in Q1 2022 and held it in 6 quarters. The position peaked at $33K in Q1 2022. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • Magnus Financial Group reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • Magnus Financial Group sold 21 Bionano Genomics shares in Q3 2023, an estimated $7.62K.
  • Magnus Financial Group first reported a position in Bionano Genomics in Q1 2022 and held it in 6 quarters.
  • Magnus Financial Group's Bionano Genomics position peaked at $33K in Q1 2022.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Magnus Financial Group's 13F filing for Q3 2023, filed 10 Oct 2023.